Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

DENVER -- Ending funding for the Ryan White HIV/AIDS Program would result in an estimated 73% increase in HIV infections in 30 states over 5 years, according to a simulation study. An analysis of ...

Globally, more than one million children who are HIV-exposed but uninfected (CHEU) are born every year. Numerous studies have documented that CHEU are at ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...

The child did not see a doctor until she was six - and had not had any vaccinations, Italian media say.

Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...

A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since retired, but a public health educator to the end, I’d like to remind ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.